UBS Maintains a 'Buy' on Methanex (MEOH); Egypt and Medicine Hat Fully Operational

UBS maintains a 'Buy' on Methanex (NASDAQ: MEOH) price target lowered from $35 to $31.50.

UBS analyst says, "We have revised our 2011/2012E EPS from $2.10/3.04 to $1.96/2.78 to reflect updated production (note Atlas will only operate at 70% in Q4 and has a major turnaround in Q1/2012), costs and realized pricing. In addition, given capital inflation for projects around the world we have increased the capital required to ultimately increase production out of Chile."

For more ratings news on Methanex click here and for the rating history of Methanex click here.

Shares of Methanex closed at $26.71 yesterday.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Deere (DE) PT Lowered to $728 at UBS as 'Ag machinery Cycle' Gets Closer
• William Blair Starts Beta Bionics, Inc. (BBNX) at Market Perform
• JPMorgan Downgrades Limbach Holdings (LMB) to Underweight